Influence of olsalazine and sulphasalazine on gastrointestinal transit

S. S. Rao, C. D. Holdsworth

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

The effect of olsalazine and sulphasalazine on stool output and transit of a solid radiolabelled meal through the stomach, small intestine and colon was measured. In six patients with ulcerative colitis intolerant of sulphasalazine, olsalazine, 250 mg q.d.s., significantly accelerated gastric emptying, mouth to caecum transit time and whole gut transit time. No significant changes were seen in the mean daily stool weight or in the mean daily stool frequency. In six normal subjects, sulphasalazine, 1 g t.d.s., had no significant effect on gastric emptying, mouth to caecum transit, whole gut transit or stool output. All six patients tolerated olsalazine without any adverse effects. In conclusion, olsalazine accelerated gastric and intestinal transit, and this effect on intestinal motor activity could be responsible for the diarrhoea reported in some patients taking this drug.

Original languageEnglish (US)
Pages (from-to)96-100
Number of pages5
JournalScandinavian Journal of Gastroenterology
Volume23
Issue numberS148
DOIs
StatePublished - Jan 1 1988
Externally publishedYes

Fingerprint

Gastrointestinal Transit
Sulfasalazine
Gastric Emptying
Mouth
Stomach
Ulcerative Colitis
Small Intestine
Meals
Diarrhea
Colon
Motor Activity
Weights and Measures
olsalazine
Pharmaceutical Preparations

Keywords

  • Gut transit
  • Olsalazine
  • Sulphasalazine
  • Ulcerative colitis

ASJC Scopus subject areas

  • Gastroenterology

Cite this

Influence of olsalazine and sulphasalazine on gastrointestinal transit. / Rao, S. S.; Holdsworth, C. D.

In: Scandinavian Journal of Gastroenterology, Vol. 23, No. S148, 01.01.1988, p. 96-100.

Research output: Contribution to journalArticle

@article{43cc88eef4344fc182c22cf480c6a3b1,
title = "Influence of olsalazine and sulphasalazine on gastrointestinal transit",
abstract = "The effect of olsalazine and sulphasalazine on stool output and transit of a solid radiolabelled meal through the stomach, small intestine and colon was measured. In six patients with ulcerative colitis intolerant of sulphasalazine, olsalazine, 250 mg q.d.s., significantly accelerated gastric emptying, mouth to caecum transit time and whole gut transit time. No significant changes were seen in the mean daily stool weight or in the mean daily stool frequency. In six normal subjects, sulphasalazine, 1 g t.d.s., had no significant effect on gastric emptying, mouth to caecum transit, whole gut transit or stool output. All six patients tolerated olsalazine without any adverse effects. In conclusion, olsalazine accelerated gastric and intestinal transit, and this effect on intestinal motor activity could be responsible for the diarrhoea reported in some patients taking this drug.",
keywords = "Gut transit, Olsalazine, Sulphasalazine, Ulcerative colitis",
author = "Rao, {S. S.} and Holdsworth, {C. D.}",
year = "1988",
month = "1",
day = "1",
doi = "10.3109/00365528809101560",
language = "English (US)",
volume = "23",
pages = "96--100",
journal = "Scandinavian Journal of Gastroenterology",
issn = "0036-5521",
publisher = "Informa Healthcare",
number = "S148",

}

TY - JOUR

T1 - Influence of olsalazine and sulphasalazine on gastrointestinal transit

AU - Rao, S. S.

AU - Holdsworth, C. D.

PY - 1988/1/1

Y1 - 1988/1/1

N2 - The effect of olsalazine and sulphasalazine on stool output and transit of a solid radiolabelled meal through the stomach, small intestine and colon was measured. In six patients with ulcerative colitis intolerant of sulphasalazine, olsalazine, 250 mg q.d.s., significantly accelerated gastric emptying, mouth to caecum transit time and whole gut transit time. No significant changes were seen in the mean daily stool weight or in the mean daily stool frequency. In six normal subjects, sulphasalazine, 1 g t.d.s., had no significant effect on gastric emptying, mouth to caecum transit, whole gut transit or stool output. All six patients tolerated olsalazine without any adverse effects. In conclusion, olsalazine accelerated gastric and intestinal transit, and this effect on intestinal motor activity could be responsible for the diarrhoea reported in some patients taking this drug.

AB - The effect of olsalazine and sulphasalazine on stool output and transit of a solid radiolabelled meal through the stomach, small intestine and colon was measured. In six patients with ulcerative colitis intolerant of sulphasalazine, olsalazine, 250 mg q.d.s., significantly accelerated gastric emptying, mouth to caecum transit time and whole gut transit time. No significant changes were seen in the mean daily stool weight or in the mean daily stool frequency. In six normal subjects, sulphasalazine, 1 g t.d.s., had no significant effect on gastric emptying, mouth to caecum transit, whole gut transit or stool output. All six patients tolerated olsalazine without any adverse effects. In conclusion, olsalazine accelerated gastric and intestinal transit, and this effect on intestinal motor activity could be responsible for the diarrhoea reported in some patients taking this drug.

KW - Gut transit

KW - Olsalazine

KW - Sulphasalazine

KW - Ulcerative colitis

UR - http://www.scopus.com/inward/record.url?scp=0024206241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024206241&partnerID=8YFLogxK

U2 - 10.3109/00365528809101560

DO - 10.3109/00365528809101560

M3 - Article

AN - SCOPUS:0024206241

VL - 23

SP - 96

EP - 100

JO - Scandinavian Journal of Gastroenterology

JF - Scandinavian Journal of Gastroenterology

SN - 0036-5521

IS - S148

ER -